Michael studied biochemistry at the University of Glasgow, before completing a PhD at Queen Mary University of London where he investigated how cells communicate. After that he worked in a science press office and joined Cancer Research UK’s News and Multimedia team in 2016, where he writes for the blog and news feed.
E-cigarettes are in the news again, but the headlines linking them to cancer don’t match the research.
A cancer blood test is in the news today, but it’s too early to say if it will work. We take a look at what questions still need to be answered.
CRISPR genome editing has received lots of attention and hype, so we took a look at what it really means for the future of cancer research.
By combining radiotherapy with different kinds of drugs, scientists hope that both can be made more effective.
Category: Science blog December 23, 2017
Our top stories this week include evidence of delays to cancer diagnosis, as well as the most googled health question of the year.
Category: Science blog December 2, 2017
This week saw diabetes and extra weight linked to cancer, as well as a case of a man whose HIV was brought under control by a lung cancer drug.
This week saw two breast cancer drugs approved in England, and Scotland winning the right to set a minimum price for units of alcohol.
This week saw new research on brain tumour and ovarian cancers, while MPs launched an inquiry into e-cigarettes.
The growing global cost of obesity was in the news this week, along with genetic tests for breast cancer and a rare childhood cancer.
In this week’s news a drug was approved for some lung cancer patients in England, and vaping could be a big piece of the quitting smoking puzzle.